Assertio director Tyree declines reelection over board retirement policy dispute

Assertio Holdings, Inc.

James L. Tyree, Compensation Committee Chair, will not stand for reelection at 2024 annual meeting.
Tyree disagreed with potential waiver of mandatory retirement policy for Board Chair Peter D. Staple.
Board declined to act on Tyree's suggestion to raise retirement age from 72 to 75.
Company provided Tyree opportunity to respond; Exhibit 17.1 includes his correspondence.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James L. Tyree

Director, Chairman of Compensation Committee

ASRT · Assertio Holdings, Inc.

Filed: April 2, 2024, 7:59 PM ET

On March 27, 2024, James L. Tyree, Chairman of the Compensation Committee of the Board of Directors (the “Board”) of Assertio Holdings, Inc. (the “Company”), informed the Board at an informal meeting that he declined to stand for reelection at the 2024 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James L. Tyree departed as Director, Chairman of Compensation Committee at Assertio Holdings, Inc..

Action: declined to stand for reelection
Role: Director, Chairman of Compensation Committee

Exact text from the filing

On March 27, 2024, James L. Tyree, Chairman of the Compensation Committee of the Board of Directors (the “Board”) of Assertio Holdings, Inc. (the “Company”), informed the Board at an informal meeting that he declined to stand for reelection at the 2024 Annual Meeting of Stockholders.

View on SEC.gov

Assertio Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-042608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.